Latest News & Features
Americas
Merck and PDL Biopharma have settled a dispute over Merck’s cancer drug Keytruda (pembrolizumab), which allegedly infringed a patent belonging to PDL. 27 April 2017
Americas
LSIPR and law firm HGF held a webinar yesterday focusing on CRISPR and how to navigate the IP landscape. 26 April 2017
Americas
The US Supreme Court will hear oral arguments from Sandoz and Amgen tomorrow, when the battle over a biosimilar of Amgen’s Neupogen will resume. 25 April 2017
Americas
Eli Lilly must pay Germany-based pharmaceutical company Erfindergemeinschaft UroPep $20 million for patent infringement. 25 April 2017
Americas
A disagreement over how pharma patents in Brazil are examined seems to have come to an end, as Breno Souza, Luisa Rezende and Silvia Costa of Clarke Modet & Co Brazil report. 25 April 2017
Americas
Momenta Pharmaceuticals and Sandoz have filed a motion to dismiss competition allegations made by Amphastar Pharmaceuticals. 24 April 2017
Americas
Eli Lilly has sued Par Pharmaceutical for patent infringement over the drug Axiron (testosterone), used to treat men with low or no testosterone. 24 April 2017
article
Medical technology company Becton Dickinson will acquire C R Bard, a business in the same industry, for $24 billion. 24 April 2017
Americas
Japan-based Sawai Pharmaceutical has agreed to buy the generic drugs business of Upsher-Smith Laboratories for nearly $1.1 billion. 21 April 2017
Americas
Harvard Stem Cells Institute, a network of stem cell scientists, has entered into a collaboration agreement with stem cells manufacturer Cellular Dynamics International. 20 April 2017